Literature DB >> 11134837

Microsatellite instability in cervical carcinoma.

T K Chung1, T Y Ip, G M Hampton, V W Wang, T H Cheung, Y F Wong.   

Abstract

OBJECTIVE: To investigate the incidence of microsatellite instability (MI) in cervical carcinoma and its relationship with clinicopathological characteristics. STUDY
DESIGN: A retrospective study of 100 cases of cervical carcinoma.
RESULTS: MI, defined as tumor-associated alterations in at least one of five dinucleotide microsatellite markers examined, was detected in 25% of the cervical carcinomas which were observed. There was a nonsignificant trend towards MI occurrence in higher grade tumors, more advanced stage and cases with poor clinical outcome.
CONCLUSION: The results suggest that microsatellite instability is present in a subset of cervical carcinoma and may be an independent prognostic factor. Further research with more samples is required.

Entities:  

Mesh:

Year:  2001        PMID: 11134837     DOI: 10.1016/s0301-2115(00)00297-9

Source DB:  PubMed          Journal:  Eur J Obstet Gynecol Reprod Biol        ISSN: 0301-2115            Impact factor:   2.435


  2 in total

1.  Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma.

Authors:  Yuan Zhang; Yi Min Shu; Shu Fang Wang; Bang Hong Da; Ze Hua Wang; Hua Bin Li
Journal:  BMC Cancer       Date:  2010-02-23       Impact factor: 4.430

2.  Loss of MSH2 protein expression is a risk factor in early stage cervical cancer.

Authors:  E R Nijhuis; H W Nijman; K A Oien; A Bell; K A ten Hoor; N Reesink-Peters; H M Boezen; H Hollema; A G J van der Zee
Journal:  J Clin Pathol       Date:  2007-07       Impact factor: 3.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.